3B BLACKBIO DX Financial Statement Analysis
|
||
|
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 48.59 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
3B BLACKBIO DX Last 5 Annual Financial Results
[BOM: 532067]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹74 Cr | ₹62 Cr | ₹81 Cr | ₹226,742 Cr | ₹29 Cr |
| Expenses | ₹41 Cr | ₹33 Cr | ₹44 Cr | ₹76,753 Cr | ₹20 Cr |
| Operating Profit (Excl OI) | ₹33 Cr | ₹29 Cr | ₹37 Cr | ₹149,989 Cr | ₹9.32 Cr |
| Other Income | ₹13 Cr | ₹7.26 Cr | ₹6.90 Cr | ₹2,892 Cr | ₹1.60 Cr |
| Interest | ₹0.13 Cr | ₹0.20 Cr | ₹0.11 Cr | ₹228 Cr | ₹0.33 Cr |
| Depreciation | ₹1.06 Cr | ₹0.86 Cr | ₹0.67 Cr | ₹616 Cr | ₹0.54 Cr |
| Profit Before Tax | ₹44 Cr | ₹35 Cr | ₹43 Cr | ₹152,036 Cr | ₹10 Cr |
| Profit After Tax | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹113,869 Cr | ₹7.69 Cr |
| Consolidated Net Profit | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹113,869 Cr | ₹7.68 Cr |
| Earnings Per Share (Rs) | ₹55.66 | ₹37.46 | ₹30.28 | ₹42.98 | ₹152.00 |
| PAT Margin (%) | 49.44 | 43.31 | 41.94 | 39.93 | 50.22 |
| ROE(%) | 19.41 | 15.42 | 14.98 | 22.59 | 138.73 |
| ROCE(%) | 26.03 | 21.21 | 20.24 | 29.92 | 179.46 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 1,152.2 Cr |
| Revenue (TTM) | : | ₹ 104.0 Cr |
| Net Profit(TTM) | : | ₹ 49.2 Cr |
| EPS (TTM) | : | ₹ 57.2 |
| P/E (TTM) | : | 23.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| 3B BLACKBIO DX | -1.6% | -2.3% | -5.9% |
| UPL | -0.1% | 11.7% | 52.8% |
| PI INDUSTRIES | -3.6% | -2.6% | -22.1% |
| SUMITOMO CHEMICAL INDIA | -4% | -11.9% | -12.3% |
| BAYER CROPSCIENCE | 0.9% | -10.9% | -27.8% |
| BASF INDIA | -3.9% | -5.9% | -34.9% |
| DHANUKA AGRITECH | -4.8% | -11.8% | -19.1% |
| SHARDA CROPCHEM | 1.2% | -6.1% | -2.1% |
| BHARAT RASAYAN | 1.4% | 7.5% | -6.5% |
3B BLACKBIO DX Revenues
[BOM: 532067]
| Y-o-Y | 19.87 % |
| 5 Yr CAGR | 26.58 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹74 Cr | 19.87 | |
| Mar2024 | ₹62 Cr | -23.32 | |
| Mar2023 | ₹81 Cr | -99.96 | |
| Mar2022 | ₹226,742 Cr | 785,153.07 | |
| Mar2021 | ₹29 Cr | - | |
3B BLACKBIO DX Operating Profit
[BOM: 532067]
| Y-o-Y | 13.30 % |
| 5 Yr CAGR | 37.16 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 13.30 | |
| Mar2024 | ₹29 Cr | -21.53 | |
| Mar2023 | ₹37 Cr | -99.98 | |
| Mar2022 | ₹149,989 Cr | 1,609,567.29 | |
| Mar2021 | ₹9.32 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -5.50 % |
| 5 Yr CAGR | 8.36 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 44.49% | -5.50 | |
| Mar2024 | 47.08% | 2.35 | |
| Mar2023 | 46% | -30.46 | |
| Mar2022 | 66.15% | 104.99 | |
| Mar2021 | 32.27% | - | |
3B BLACKBIO DX Profit After Tax
[BOM: 532067]
| Y-o-Y | 23.77 % |
| 5 Yr CAGR | 43.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 23.77 | |
| Mar2024 | ₹26 Cr | -19.45 | |
| Mar2023 | ₹32 Cr | -99.97 | |
| Mar2022 | ₹113,869 Cr | 1,483,149.29 | |
| Mar2021 | ₹7.68 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 14.15 % |
| 5 Yr CAGR | -0.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 49.44 % | 14.15 | |
| Mar2024 | 43.31 % | 3.27 | |
| Mar2023 | 41.94 % | 5.03 | |
| Mar2022 | 39.93 % | -20.49 | |
| Mar2021 | 50.22 % | - | |
3B BLACKBIO DX Earnings Per Share (EPS)
[BOM: 532067]
| Y-o-Y | 48.59 % |
| 5 Yr CAGR | -22.21 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹56 | 48.59 | |
| Mar2024 | ₹37 | 23.71 | |
| Mar2023 | ₹30 | -29.55 | |
| Mar2022 | ₹43 | -71.72 | |
| Mar2021 | ₹152 | - | |
3B BLACKBIO DX Return on Capital Employed (ROCE)
[BOM: 532067]
| Y-o-Y | 22.73 % |
| 5 Yr CAGR | -38.29 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 26.03% | 22.73 | |
| Mar2024 | 21.21% | 4.79 | |
| Mar2023 | 20.24% | -32.35 | |
| Mar2022 | 29.92% | -83.33 | |
| Mar2021 | 179.46% | - | |
3B BLACKBIO DX Share Price vs Sensex
| Current Share Price | : | ₹1,339.8 |
| Current MarketCap | : | ₹ 1,152.2 Cr |
| Updated EOD on | : | Nov 18,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| 3B BLACKBIO DX | -1.6% |
-2.3% |
-5.9% |
| SENSEX | 1% |
2.5% |
6.5% |
3B BLACKBIO DX related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 0.7% | 0.2% | 2.5% |
| BSE SMALLCAP | 0.3% | -0.1% | -2.4% |
No NSE index found
You may also like the below Video Courses
FAQ about 3B BLACKBIO DX Financials
How the annual revenues of 3B BLACKBIO DX have changed ?
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
How the Earnings per Share (EPS) of 3B BLACKBIO DX have changed?
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 48.59 % YoY .
Check out Intrinsic Value of Peers of 3B BLACKBIO DX
|
Intrinsic Value of UPL LTD Intrinsic Value of PI INDUSTRIES LTD Intrinsic Value of SUMITOMO CHEMICAL INDIA LTD Intrinsic Value of BAYER CROPSCIENCE LTD Intrinsic Value of BASF INDIA LTD |
Compare Stock Analytics of Peers of 3B BLACKBIO DX
UPL LTD vs PI INDUSTRIES LTD vs SUMITOMO CHEMICAL INDIA LTD
BAYER CROPSCIENCE LTD vs BASF INDIA LTD vs
UPL LTD vs PI INDUSTRIES LTD vs SUMITOMO CHEMICAL INDIA LTD
BAYER CROPSCIENCE LTD vs BASF INDIA LTD vs
